The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.
Terns' lead candidate TERN-701 is an investigational oral  allosteric BCR::ABL1 tyrosine kinase inhibitor c urrently in Phase 1/2 development for certain patients with CML
RAHWAY, N.J., & FOSTER CITY, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN), a clinical-
Merck is nearing a ​roughly $6 billion all-cash ‌deal to buy biotech firm Terns ​Pharma , the ​Financial Times reported on ⁠Tuesday, citing ​people familiar with ​the matter.
Diversified Trust Co. lessened its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 3.5% during the fourth quarter, according to the company in its most recent filing with the Securities and E
Contravisory Investment Management Inc. boosted its position in shares of Merck and Co., Inc. (NYSE: MRK) by 19,435.3% in the fourth quarter, according to the company in its most recent disclosure wit
Clear Trail Advisors LLC purchased a new stake in shares of Merck and Co., Inc. (NYSE: MRK) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exc
Central Bank and Trust Co. decreased its position in shares of Merck and Co., Inc. (NYSE: MRK) by 31.0% during the undefined quarter, according to the company in its most recent 13F filing with the Se
CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year res
Merck (MRK) reached $115.68 at the closing of the latest trading day, reflecting a +1.31% change compared to its last close.
Spartan Planning and Wealth Management bought a new position in Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commissi
CIBC Private Wealth Group LLC lowered its position in shares of Merck and Co., Inc. (NYSE: MRK) by 3.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange C
Catherine Avery Investment Management LLC decreased its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 8.9% during the fourth quarter, according to its most recent disclosure with the SEC. T
Stock News Fed set to ease bank capital rules: The Federal Reserve is poised to cut capital requirements by about 4.8% for the largest lenders, a move that coul
The 10-year Treasury yield sits at 4.23% today, and that number matters more than most retirees realize. It represents the baseline. That is, what you can earn with zero risk. Any dividend ETF benchma
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE